Morphine, solution for injection, 10 mg/ml in 1 ml, Fentanyl, solution for injection, 0.05 mg/ml, in 2 ml, Diazepam, solution for injection, 5 mg/ml in 2 ml, Ketamine, solution for injection, 50 mg/ml in 2 ml, Promedol solution for injection, 20 mg/ml in 1 ml, Nalbuphine solution for injection, 10 mg/ml in 1 ml

This tender is for the procurement of various injectable narcotic and analgesic medications, primarily for pain management and sedation. The procuring entity requires Morphine (10 mg/ml), Fentanyl (0.05 mg/ml), Diazepam (5 mg/ml), Ketamine (50 mg/ml), Promedol (20 mg/ml), and Nalbuphine (10 mg/ml), all in solution for injection form and specified volumes. These medications fall under CPV code 33660000-4 (Medicinal products for the treatment of nervous system diseases and sensory organ diseases). The procurement is crucial for healthcare facilities, likely hospitals or clinics, to manage severe pain, provide anesthesia, and sedate patients during medical procedures or critical care. The tender aims to ensure a consistent and reliable supply of these essential, controlled substances, adhering to all regulatory requirements for their handling and distribution. The objective is to guarantee that medical professionals have access to these vital medications for effective patient treatment and care.

This is a supplies contract in the health and medical services sector. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 951,968.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.